Cargando…
A closer look at ARSA activity in a patient with metachromatic leukodystrophy
Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease mainly caused by a deficiency of arylsulfatase A activity. The typical clinical course of patients with the late infantile form includes a regression in motor skills with progression to dysphagia, seizures, hypoto...
Autores principales: | Doherty, Kathleen, Frazier, S. Barron, Clark, Matthew, Childers, Anna, Pruthi, Sumit, Wenger, David A., Duis, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383325/ https://www.ncbi.nlm.nih.gov/pubmed/30828547 http://dx.doi.org/10.1016/j.ymgmr.2019.100460 |
Ejemplares similares
-
Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic Leukodystrophy
por: Chen, Li, et al.
Publicado: (2018) -
Population Carrier Rates of Pathogenic ARSA Gene Mutations: Is Metachromatic Leukodystrophy Underdiagnosed?
por: Ługowska, Agnieszka, et al.
Publicado: (2011) -
An arylsulphatase A (ARSA) frameshift mutation (289insG) in metachromatic leukodystrophy (MLD)
por: Perkins, Kelly J, et al.
Publicado: (2005) -
Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD)
por: Hettiarachchi, D., et al.
Publicado: (2019) -
Identification of a missense ARSA mutation in metachromatic leukodystrophy and its potential pathogenic mechanism
por: Guo, Liyuan, et al.
Publicado: (2020)